Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double‐Blind Randomized Crossover Placebo‐Controlled Trial
- DOI
- 10.1111/acel.70093
- Published
- 2025-06-03
- Container
- Aging Cell
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/acel.70093,
title = {Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double‐Blind Randomized Crossover Placebo‐Controlled Trial},
author = {Mayumi Shoji and Hisaya Kato and Masaya Koshizaka and Hiyori Kaneko and Yusuke Baba and Takahiro Ishikawa and Naoya Teramoto and Daisuke Kinoshita and Ayano Yamaguchi and Yukari Maeda and Yosuke Inaba and Yuki Shiko and Yoshihito Ozawa and Vilhelm A. Bohr and Yoshiro Maezawa and Koutaro Yokote},
year = {2025},
journal = {Aging Cell},
doi = {10.1111/acel.70093},
url = {https://doi.org/10.1111/acel.70093}
}RIS
TY - JOUR TI - Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double‐Blind Randomized Crossover Placebo‐Controlled Trial AU - Mayumi Shoji AU - Hisaya Kato AU - Masaya Koshizaka AU - Hiyori Kaneko AU - Yusuke Baba AU - Takahiro Ishikawa AU - Naoya Teramoto AU - Daisuke Kinoshita AU - Ayano Yamaguchi AU - Yukari Maeda AU - Yosuke Inaba AU - Yuki Shiko AU - Yoshihito Ozawa AU - Vilhelm A. Bohr AU - Yoshiro Maezawa AU - Koutaro Yokote PY - 2025 JO - Aging Cell DO - 10.1111/acel.70093 UR - https://doi.org/10.1111/acel.70093 ER -
APA
Shoji, M., Kato, H., Koshizaka, M., Kaneko, H., Baba, Y., Ishikawa, T., Teramoto, N., Kinoshita, D., Yamaguchi, A., Maeda, Y., Inaba, Y., Shiko, Y., Ozawa, Y., Bohr, V. A., Maezawa, Y., & Yokote, K. (2025). Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double‐Blind Randomized Crossover Placebo‐Controlled Trial. Aging Cell. https://doi.org/10.1111/acel.70093
Source records
- crossref · retrieved 2026-09-27T00:33:35.335Z